https://www.selleckchem.com/pr....oducts/disodium-Crom
h as CGRP antagonists for migraine. Our findings provide recent rates of vascular disease in patients with migraine. In the future, this information will be useful to help inform clinical riskbenefit decision making when assessing the use of therapies such as CGRP antagonists for migraine.Working memory (WM) is vulnerable to age-related decline, particularly under high loads. Visual alpha oscillations contribute to WM performance in younger adults, and although alpha decreases in power and frequency with age, it is unclear